2016
DOI: 10.1093/humrep/dew187
|View full text |Cite
|
Sign up to set email alerts
|

Development of a new clinically applicable device for embryo evaluation which measures embryo oxygen consumption

Abstract: Not applicable.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
41
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 46 publications
(45 citation statements)
references
References 40 publications
4
41
0
Order By: Relevance
“…The existing methods from the 1990s for measuring oxygen consumption failed to become a gold standard due to their lack of high sensitivity coupled by their invasive nature. Another innovative method, scanning electrochemical microscopy, employed to measure the oxygen consumption rate failed to excite embryologists as reported by Kurosawa et al due to the fact that it requires micromanipulation and further training (73). Finally, a new device developed by Kurosawa et al that included a chip sensing embryo respiration monitoring system achieved an automated measurement of oxygen consumption rate in a satisfactory fashion (73).…”
Section: Latest Trendsmentioning
confidence: 99%
See 1 more Smart Citation
“…The existing methods from the 1990s for measuring oxygen consumption failed to become a gold standard due to their lack of high sensitivity coupled by their invasive nature. Another innovative method, scanning electrochemical microscopy, employed to measure the oxygen consumption rate failed to excite embryologists as reported by Kurosawa et al due to the fact that it requires micromanipulation and further training (73). Finally, a new device developed by Kurosawa et al that included a chip sensing embryo respiration monitoring system achieved an automated measurement of oxygen consumption rate in a satisfactory fashion (73).…”
Section: Latest Trendsmentioning
confidence: 99%
“…Another innovative method, scanning electrochemical microscopy, employed to measure the oxygen consumption rate failed to excite embryologists as reported by Kurosawa et al due to the fact that it requires micromanipulation and further training (73). Finally, a new device developed by Kurosawa et al that included a chip sensing embryo respiration monitoring system achieved an automated measurement of oxygen consumption rate in a satisfactory fashion (73). No matter how exciting these latest trends sound, usability within the clinical spectrum of the IVF laboratory is a required condition that should be seriously accounted for.…”
Section: Latest Trendsmentioning
confidence: 99%
“…[43][44][45] In one such device, a single mouse embryo was positioned in a microwell surrounded by electrodes (Fig. 8), and the O 2 consumption of the two-cell, morula, and blastocyst stages was successfully measured.…”
Section: Electrode Array Devicesmentioning
confidence: 99%
“…The “quiet” metabolism of embryos shifts from oxidative phosphorylation to glycolysis during the morula and blastocyst stages—particularly in cells of the inner cell mass, whereas trophoblasts consume much more oxygen (Houghton, ; reviewed by Gardner and Harvey, ). This metabolic characteristic, first discovered by Otto Warburg in tumors (Warburg, ), is shared by proliferating cells (Heiden, Cantley, & Thompson, ; Lunt & Vander Heiden, ) and persists through later embryonic stages (Krisher & Prather, ; Redel et al, ; Smith & Sturmey, ), although the increasing population of oxidative phosphorylation‐utilizing trophoblasts could account for the net increase in oxygen consumption reported between the morula and blastocyst stages (Kurosawa et al, ). This shift to glycolytic metabolism in the inner cell mass is not a result of anaerobic glycolysis, however, because embryonic stem cells, derived from the inner cell mass (Evans & Kaufman, ), also exhibit high rates of glycolysis over oxidative phosphorylation when they are cultured in high oxygen‐partial pressure conditions (Turner et al, ).…”
Section: Embryo Development and The In Vivo Environmentmentioning
confidence: 99%